Accelerating anticancer drug development — opportunities and trade-offs

Accelerating anticancer drug development — opportunities and trade-offsAccelerating anticancer drug development — opportunities and trade-offs, Published online: 01 October 2018; doi:10.1038/s41571-018-0102-3With the expansion of the precision medicine paradigm, seamless trial approaches to drug development hold great promise for accelerating the accessibility of novel therapeutic agents but are also accompanied by important trade-offs. The authors describe several opportunities to improve the efficiency of drug development in oncology, as well as new mechanisms to obtain information about anticancer therapies throughout their life cycle.

Source: Nature Clinical Practice Oncology - October 1, 2018 Category: Cancer & Oncology Authors: Sharyl J. Nass Mace L. Rothenberg Rebecca Pentz Hedvig Hricak Amy Abernethy Kenneth Anderson Amanda Wagner Gee R. Donald Harvey Steven Piantadosi Monica M. Bertagnolli Deborah Schrag Richard L. Schilsky Source Type: research